{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T07:56:22Z","timestamp":1791964582451,"version":"4.3.4"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,10]]},"DOI":"10.7759\/cureus.89736","type":"journal-article","created":{"date-parts":[[2025,8,10]],"date-time":"2025-08-10T16:14:47Z","timestamp":1754842487000},"source":"Crossref","is-referenced-by-count":3,"title":["Effectiveness and Safety of Direct Oral Anticoagulants Versus Warfarin in Patients With Mechanical Heart Valves: A Systematic Review"],"prefix":"10.7759","author":[{"given":"Bethel T","family":"Mandefro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sri Vidya","family":"Sundara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamide","family":"Busmail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sasika","family":"Weerakoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sravanthi","family":"Avula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laraib","family":"Iftikhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.119.041105","article-title":"How did we get here?: a historical review and critical analysis of anticoagulation therapy following mechanical valve replacement","volume":"140","author":"MacIsaac S","year":"2019","unstructured":"MacIsaac S, Jaffer IH, Belley-C\u00f4t\u00e9 EP, McClure GR, Eikelboom JW, Whitlock RP. How did we get here?: a historical review and critical analysis of anticoagulation therapy following mechanical valve replacement. Circulation. 2019, 140:1933-42. 10.1161\/CIRCULATIONAHA.119.041105","journal-title":"Circulation"},{"key":"ref2","unstructured":"iData Research. Over 290,000 heart valve replacements per year in the United States by 2029. (2024). Accessed: June 2, 2025: https:\/\/idataresearch.com\/heart-valve-replacements-per-year-in-the-united-states\/."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13133768","article-title":"Mechanical valves: past, present, and future - a review","volume":"13","author":"Leviner DB","year":"2024","unstructured":"Leviner DB, Abraham D, Ronai T, Sharoni E. Mechanical valves: past, present, and future - a review. J Clin Med. 2024, 13:10.3390\/jcm13133768","journal-title":"J Clin Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.14628","article-title":"Optimizing age-specific outcomes after mechanical vs bioprosthetic prosthetic heart valve replacement","volume":"6","author":"Otto CM","year":"2023","unstructured":"Otto CM. Optimizing age-specific outcomes after mechanical vs bioprosthetic prosthetic heart valve replacement. JAMA Netw Open. 2023, 6:e2314628. 10.1001\/jamanetworkopen.2023.14628","journal-title":"JAMA Netw Open"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3390\/cells11203214","article-title":"Anticoagulants: a short history, their mechanism of action, pharmacology, and indications","volume":"11","author":"Heestermans M","year":"2022","unstructured":"Heestermans M, Poenou G, Hamzeh-Cognasse H, Cognasse F, Bertoletti L. Anticoagulants: a short history, their mechanism of action, pharmacology, and indications. Cells. 2022, 11:10.3390\/cells11203214","journal-title":"Cells"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0b013e3182742cf6","article-title":"2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"127","author":"O'Gara PT","year":"2013","unstructured":"O'Gara PT, Kushner FG, Ascheim DD, et al.. 2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines. Circulation. 2013, 127:e362-425. 10.1161\/CIR.0b013e3182742cf6","journal-title":"Circulation"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1300615","article-title":"Dabigatran versus warfarin in patients with mechanical heart valves","volume":"369","author":"Eikelboom JW","year":"2013","unstructured":"Eikelboom JW, Connolly SJ, Brueckmann M, et al.. Dabigatran versus warfarin in patients with mechanical heart valves. N Engl J Med. 2013, 369:1206-14. 10.1056\/NEJMoa1300615","journal-title":"N Engl J Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.115.002776","article-title":"Use of direct oral anticoagulants in patients with atrial fibrillation and valvular heart lesions","volume":"5","author":"Di Biase L","year":"2016","unstructured":"Di Biase L. Use of direct oral anticoagulants in patients with atrial fibrillation and valvular heart lesions. J Am Heart Assoc. 2016, 5:10.1161\/JAHA.115.002776","journal-title":"J Am Heart Assoc"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/medicina55080437","article-title":"\u201cA tale of two cities\u201d: anticoagulation management in patients with atrial fibrillation and prosthetic valves in the era of direct oral anticoagulants","volume":"55","author":"Palmiero G","year":"2019","unstructured":"Palmiero G, Melillo E, Rubino AS. \u201cA tale of two cities\u201d: anticoagulation management in patients with atrial fibrillation and prosthetic valves in the era of direct oral anticoagulants. Medicina (Kaunas). 2019, 55:10.3390\/medicina55080437","journal-title":"Medicina (Kaunas)"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.1259","article-title":"Off-label use of direct oral anticoagulants in patients receiving surgical mechanical and bioprosthetic heart valves","volume":"4","author":"Kalra A","year":"2021","unstructured":"Kalra A, Raza S, Jafry BH, King HE, Lahorra JA, Svensson LG, Kapadia SR. Off-label use of direct oral anticoagulants in patients receiving surgical mechanical and bioprosthetic heart valves. JAMA Netw Open. 2021, 4:e211259. 10.1001\/jamanetworkopen.2021.1259","journal-title":"JAMA Netw Open"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1055\/s-0043-1777827","article-title":"Outcomes of patients with a mechanical heart valve and poor anticoagulation control on warfarin","volume":"124","author":"Johansson I","year":"2024","unstructured":"Johansson I, Benz AP, Kovalova T, et al.. Outcomes of patients with a mechanical heart valve and poor anticoagulation control on warfarin. Thromb Haemost. 2024, 124:613-24. 10.1055\/s-0043-1777827","journal-title":"Thromb Haemost"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.124.035478","article-title":"Direct oral anticoagulants compared with warfarin in patients with atrial fibrillation and valvular heart disease without mechanical valves","volume":"14","author":"Dawwas GK","year":"2025","unstructured":"Dawwas GK, Lewis JD, Cuker A. Direct oral anticoagulants compared with warfarin in patients with atrial fibrillation and valvular heart disease without mechanical valves. J Am Heart Assoc. 2025, 14:e035478. 10.1161\/JAHA.124.035478","journal-title":"J Am Heart Assoc"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1056\/EVIDoa2300067","article-title":"Apixaban or warfarin in patients with an On-X mechanical aortic valve","volume":"2","author":"Wang TY","year":"2023","unstructured":"Wang TY, Svensson LG, Wen J, et al.. Apixaban or warfarin in patients with an On-X mechanical aortic valve. NEJM Evid. 2023, 2:EVIDoa2300067. 10.1056\/EVIDoa2300067","journal-title":"NEJM Evid"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2020.06.014","article-title":"Rationale and design of PROACT Xa: a randomized, multicenter, open-label, clinical trial to evaluate the efficacy and safety of apixaban versus warfarin in patients with a mechanical On-X aortic heart valve","volume":"227","author":"Jawitz OK","year":"2020","unstructured":"Jawitz OK, Wang TY, Lopes RD, et al.. Rationale and design of PROACT Xa: a randomized, multicenter, open-label, clinical trial to evaluate the efficacy and safety of apixaban versus warfarin in patients with a mechanical On-X aortic heart valve. Am Heart J. 2020, 227:91-9. 10.1016\/j.ahj.2020.06.014","journal-title":"Am Heart J"},{"key":"ref15","article-title":"Warfarin versus direct oral anticoagulants in patients with artificial heart valves: a systematic review and meta-analysis","volume":"4","author":"Srivastava Y","year":"2024","unstructured":"Srivastava Y, Deo S, Almader-Douglas D, et al.. Warfarin versus direct oral anticoagulants in patients with artificial heart valves: a systematic review and meta-analysis. Clin Case Rep Int. 2024, 4:8.","journal-title":"Clin Case Rep Int"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s40268-019-0274-z","article-title":"Comparison of the new oral anticoagulants and warfarin in patients with atrial fibrillation and valvular heart disease: systematic review and meta-analysis","volume":"19","author":"de Souza Lima Bitar Y","year":"2019","unstructured":"de Souza Lima Bitar Y, Neto MG, Filho JA, et al.. Comparison of the new oral anticoagulants and warfarin in patients with atrial fibrillation and valvular heart disease: systematic review and meta-analysis. Drugs R D. 2019, 19:117-26. 10.1007\/s40268-019-0274-z","journal-title":"Drugs R D"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1186\/s12872-019-1089-0","article-title":"Comparing clinical outcomes of NOACs with warfarin on atrial fibrillation with valvular heart diseases: a meta-analysis","volume":"19","author":"He Q","year":"2019","unstructured":"He Q, Sze CY, Shum TY, et al.. Comparing clinical outcomes of NOACs with warfarin on atrial fibrillation with valvular heart diseases: a meta-analysis. BMC Cardiovasc Disord. 2019, 19:113. 10.1186\/s12872-019-1089-0","journal-title":"BMC Cardiovasc Disord"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1186\/s13019-024-02863-z","article-title":"Antithrombotic management after aortic valve replacement with biological prosthesis: a meta-analysis","volume":"19","author":"Uimonen M","year":"2024","unstructured":"Uimonen M, Kuitunen I, Ponkilainen V, Mennander A, Mattila MS. Antithrombotic management after aortic valve replacement with biological prosthesis: a meta-analysis. J Cardiothorac Surg. 2024, 19:385. 10.1186\/s13019-024-02863-z","journal-title":"J Cardiothorac Surg"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.117.005835","article-title":"Effects of non-vitamin K antagonist oral anticoagulants versus warfarin in patients with atrial fibrillation and valvular heart disease: a systematic review and meta-analysis","volume":"6","author":"Pan KL","year":"2017","unstructured":"Pan KL, Singer DE, Ovbiagele B, Wu YL, Ahmed MA, Lee M. Effects of non-vitamin K antagonist oral anticoagulants versus warfarin in patients with atrial fibrillation and valvular heart disease: a systematic review and meta-analysis. J Am Heart Assoc. 2017, 6:10.1161\/JAHA.117.005835","journal-title":"J Am Heart Assoc"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0252549","article-title":"Meta-analysis comparing direct oral anticoagulants versus vitamin K antagonists in patients with left ventricular thrombus","volume":"16","author":"Kido K","year":"2021","unstructured":"Kido K, Ghaffar YA, Lee JC, Bianco C, Shimizu M, Shiga T, Hashiguchi M. Meta-analysis comparing direct oral anticoagulants versus vitamin K antagonists in patients with left ventricular thrombus. PLoS One. 2021, 16:e0252549. 10.1371\/journal.pone.0252549","journal-title":"PLoS One"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/398219-effectiveness-and-safety-of-direct-oral-anticoagulants-versus-warfarin-in-patients-with-mechanical-heart-valves-a-systematic-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,10]],"date-time":"2025-08-10T16:14:48Z","timestamp":1754842488000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/398219-effectiveness-and-safety-of-direct-oral-anticoagulants-versus-warfarin-in-patients-with-mechanical-heart-valves-a-systematic-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,10]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.89736","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8,10]]}}}